Methods: We analyzed data from pathogenic bacterial isolates from blood, cerebrospinal, peritoneal, and pleural fluid from AMR surveillance data from 2018-2021. We calculated the proportions of isolates that were resistant to common antimicrobial classes. We use the chi-square test for trends to evaluate changes in AMR resistance over the study period.